Dainippon Sumitomo (DS) Pharma Animal Health starts clinical trial on stem cell therapy for dogs

In the experimental design, mesenchymal stem cells are obtained from adipose tissue and applied to dogs who suffer from hernia. The company, a subsidiary of DS Pharma, cooperates with J-ARM Co., Osaka.

Source: DS Pharma Animal Health news release, April 19, 2018

Request a quote for deeper information from

© 2018 Window to Japan - Bio 4 Business - Imprint